TotalMarketCap

Teva Pharmaceutical Industries

TEVANYSE IsraelHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$48.733 B

$41.77 -0.20%

Close of 6 Nov 2026

As of 6 Nov 2026, Teva Pharmaceutical Industries (TEVA) has a market capitalization of $48.7B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$17.3B

#256 by revenue

Earnings

$1.41B

#298 by earnings

Shares outstanding

1,166,826,784

Latest filing cover page

P/E ratio

34.6

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #14Regeneron PharmaceuticalsREGN$93.4B
  2. #15Takeda PharmaceuticalTAK$67.1B
  3. #16Teva Pharmaceutical IndustriesTEVA$48.7B
  4. #17BeOne MedicinesONC$44.0B
  5. #18Royalty PharmaRPRX$38.9B

What if Teva Pharmaceutical Industries were worth as much as…

Open the what-if tool →

Gold $28.2T

$24,199.71

Per share 579× higher

Bitcoin $1.53T

$1,309.40

Per share 31.4× higher

Apple $5.02T

$4,298.65

Per share 103× higher

Or at a round number

$100.0B$200.0B$500.0B$1.00T

Where these numbers come from

Share counts and financials for Teva Pharmaceutical Industries are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.